BSM Chemical Co.,Ltd. (SHE:300796)
China · Delayed Price · Currency is CNY 8.27
-0.10 (-1.19%)
May 19, 2026, 3:04 PM CST
BSM Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,452 | 1,521 | 1,327 | 698.91 | 767.83 | 529.83 |
Other Revenue | 2.14 | 2.14 | 0.77 | 0.28 | 0.25 | 0.18 |
| 1,454 | 1,523 | 1,328 | 699.19 | 768.07 | 530.02 | |
Revenue Growth (YoY) | 4.10% | 14.69% | 89.97% | -8.97% | 44.91% | 31.02% |
Cost of Revenue | 1,243 | 1,288 | 1,155 | 458.05 | 474.63 | 374.82 |
Gross Profit | 211.4 | 235.62 | 173.72 | 241.15 | 293.44 | 155.2 |
Selling, General & Admin | 158.7 | 160.69 | 154.24 | 99.41 | 58.87 | 47.28 |
Research & Development | 40.15 | 41.79 | 45.52 | 40.03 | 37.58 | 32.6 |
Other Operating Expenses | 8.34 | 5.79 | 4.23 | -2.53 | -0.18 | 4.49 |
Operating Expenses | 206.56 | 208.24 | 206.61 | 133.64 | 99.96 | 85.11 |
Operating Income | 4.84 | 27.38 | -32.89 | 107.51 | 193.48 | 70.09 |
Interest Expense | -37.74 | -29.94 | -24.54 | -7.57 | -9.32 | -5.56 |
Interest & Investment Income | 10.85 | 10.85 | 9.83 | 8.63 | 6.36 | 4.43 |
Currency Exchange Gain (Loss) | 4.8 | 4.8 | 5.31 | 3.56 | 7.76 | -0.57 |
Other Non Operating Income (Expenses) | -2.9 | -3.1 | -3.96 | 0.92 | -0.96 | -1.44 |
EBT Excluding Unusual Items | -20.15 | 9.98 | -46.24 | 113.04 | 197.33 | 66.94 |
Gain (Loss) on Sale of Investments | -10.74 | -10.35 | -14.09 | -0.88 | -4.01 | -0.67 |
Gain (Loss) on Sale of Assets | 0.3 | 0.3 | 0.05 | 0.11 | 0.25 | 0 |
Asset Writedown | -1.6 | -1.63 | -2.66 | -1.53 | -9.45 | -3.39 |
Other Unusual Items | 5.98 | 4.39 | 4.99 | - | -1.02 | 1.9 |
Pretax Income | -26.22 | 2.69 | -57.96 | 110.74 | 183.09 | 64.79 |
Income Tax Expense | -19.6 | -14.91 | -21.05 | 18.55 | 25.92 | 7.52 |
Earnings From Continuing Operations | -6.63 | 17.6 | -36.91 | 92.19 | 157.18 | 57.27 |
Minority Interest in Earnings | 7.68 | 6.46 | 4.05 | -3.78 | -4.29 | -0.88 |
Net Income | 1.05 | 24.07 | -32.86 | 88.41 | 152.88 | 56.39 |
Net Income to Common | 1.05 | 24.07 | -32.86 | 88.41 | 152.88 | 56.39 |
Net Income Growth | - | - | - | -42.17% | 171.10% | 46.81% |
Shares Outstanding (Basic) | 282 | 301 | 365 | 368 | 356 | 299 |
Shares Outstanding (Diluted) | 282 | 301 | 365 | 368 | 356 | 299 |
Shares Change (YoY) | -24.57% | -17.61% | -0.87% | 3.61% | 19.10% | -1.29% |
EPS (Basic) | 0.00 | 0.08 | -0.09 | 0.24 | 0.43 | 0.19 |
EPS (Diluted) | 0.00 | 0.08 | -0.09 | 0.24 | 0.43 | 0.19 |
EPS Growth | - | - | - | -44.19% | 127.63% | 48.74% |
Free Cash Flow | -173.46 | -112.61 | -254.53 | -245.63 | -83.41 | -120.02 |
Free Cash Flow Per Share | -0.61 | -0.37 | -0.70 | -0.67 | -0.23 | -0.40 |
Dividend Per Share | 0.200 | 0.200 | - | 0.040 | 0.067 | 0.024 |
Dividend Growth | - | - | - | -40.03% | 180.25% | 20.20% |
Gross Margin | 14.54% | 15.47% | 13.08% | 34.49% | 38.20% | 29.28% |
Operating Margin | 0.33% | 1.80% | -2.48% | 15.38% | 25.19% | 13.22% |
Profit Margin | 0.07% | 1.58% | -2.47% | 12.65% | 19.91% | 10.64% |
Free Cash Flow Margin | -11.93% | -7.39% | -19.16% | -35.13% | -10.86% | -22.64% |
EBITDA | 112.97 | 133.73 | 66.36 | 161.3 | 241.38 | 112.86 |
EBITDA Margin | 7.77% | 8.78% | 5.00% | 23.07% | 31.43% | 21.29% |
D&A For EBITDA | 108.13 | 106.35 | 99.24 | 53.8 | 47.9 | 42.77 |
EBIT | 4.84 | 27.38 | -32.89 | 107.51 | 193.48 | 70.09 |
EBIT Margin | 0.33% | 1.80% | -2.48% | 15.38% | 25.19% | 13.22% |
Effective Tax Rate | - | - | - | 16.75% | 14.16% | 11.60% |
Revenue as Reported | 1,454 | 1,523 | 1,328 | 699.19 | 768.07 | 530.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.